Joincare Pharmaceutical Group Industry Co Ltd (600380) — Financial Flexibility Index
Joincare Pharmaceutical Group Industry Co Ltd (600380) has a Financial Flexibility Index of 0.10x as of September 2025. Free cash flow of CN¥1.25 Billion (operating CF CN¥1.09 Billion minus capex CN¥155.85 Million) represents 0% of total liabilities (CN¥11.93 Billion). Check 600380 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Joincare Pharmaceutical Group Industry Co Ltd Financial Flexibility Index (1999–2025)
Historical Financial Flexibility Index trend for Joincare Pharmaceutical Group Industry Co Ltd across 27 annual periods. See Joincare Pharmaceutical Group Industry C short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Joincare Pharmaceutical Group Industry Co Ltd (1999–2025)
Year-by-year free cash flow to debt coverage for Joincare Pharmaceutical Group Industry Co Ltd. For the full company profile including market capitalisation, see how much is Joincare Pharmaceutical Group Industry C worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | CN¥4.66 Billion | CN¥3.89 Billion | CN¥11.05 Billion | ▲ +12.6% |
| 2024 | 0.37x | CN¥4.62 Billion | CN¥3.64 Billion | CN¥12.32 Billion | ▲ +1.6% |
| 2023 | 0.37x | CN¥5.06 Billion | CN¥3.93 Billion | CN¥13.72 Billion | ▼ -1.4% |
| 2022 | 0.37x | CN¥5.13 Billion | CN¥3.98 Billion | CN¥13.71 Billion | ▼ 0.0% |
| 2021 | 0.37x | CN¥4.08 Billion | CN¥2.56 Billion | CN¥10.92 Billion | ▼ -13.5% |
| 2020 | 0.43x | CN¥3.86 Billion | CN¥3.02 Billion | CN¥8.92 Billion | ▲ +15.4% |
| 2019 | 0.37x | CN¥3.02 Billion | CN¥2.31 Billion | CN¥8.05 Billion | ▲ +31.2% |
| 2018 | 0.29x | CN¥2.48 Billion | CN¥1.83 Billion | CN¥8.69 Billion | ▲ +4.4% |
| 2017 | 0.27x | CN¥2.35 Billion | CN¥1.87 Billion | CN¥8.59 Billion | ▼ -14.1% |
| 2016 | 0.32x | CN¥2.14 Billion | CN¥1.64 Billion | CN¥6.74 Billion | ▲ +11.1% |
| 2015 | 0.29x | CN¥1.86 Billion | CN¥1.26 Billion | CN¥6.49 Billion | ▼ -11.6% |
| 2014 | 0.32x | CN¥1.80 Billion | CN¥979.46 Million | CN¥5.54 Billion | ▼ -5.5% |
| 2013 | 0.34x | CN¥1.62 Billion | CN¥635.52 Million | CN¥4.72 Billion | ▼ -10.6% |
| 2012 | 0.38x | CN¥1.60 Billion | CN¥734.36 Million | CN¥4.16 Billion | ▲ +18.1% |
| 2011 | 0.33x | CN¥1.09 Billion | CN¥650.36 Million | CN¥3.35 Billion | ▼ -65.6% |
| 2010 | 0.94x | CN¥1.69 Billion | CN¥1.11 Billion | CN¥1.79 Billion | ▲ +80.4% |
| 2009 | 0.52x | CN¥912.53 Million | CN¥605.66 Million | CN¥1.74 Billion | ▲ +52.4% |
| 2008 | 0.34x | CN¥672.72 Million | CN¥455.01 Million | CN¥1.96 Billion | ▼ -1.3% |
| 2007 | 0.35x | CN¥675.89 Million | CN¥429.26 Million | CN¥1.94 Billion | ▼ -15.0% |
| 2006 | 0.41x | CN¥762.69 Million | CN¥272.50 Million | CN¥1.86 Billion | ▼ -23.6% |
| 2005 | 0.54x | CN¥730.86 Million | CN¥363.13 Million | CN¥1.36 Billion | ▲ +67.3% |
| 2004 | 0.32x | CN¥461.61 Million | CN¥241.71 Million | CN¥1.44 Billion | ▲ +56.7% |
| 2003 | 0.20x | CN¥282.85 Million | CN¥172.25 Million | CN¥1.38 Billion | ▼ -68.1% |
| 2002 | 0.64x | CN¥328.22 Million | CN¥236.13 Million | CN¥511.40 Million | ▼ -24.3% |
| 2001 | 0.85x | CN¥293.34 Million | CN¥223.79 Million | CN¥346.20 Million | ▲ +76.4% |
| 2000 | 0.48x | CN¥241.07 Million | CN¥171.61 Million | CN¥501.77 Million | ▲ +48.7% |
| 1999 | 0.32x | CN¥158.97 Million | CN¥109.82 Million | CN¥492.14 Million | — |